United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares worth $5,031,247.39 - UTHR News | RalliesUnited Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares worth $5,031,247.39
U
UTHR• Rothblatt reports exercise and sale of shares
- United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 21, 2026.
- The trust then sold 9,500 shares in the market at weighted-average prices from USD 512.71 to USD 527.71.
- Trust holdings fell to 324,443 shares following the transactions.
- The filing also reported 40,513 shares held directly.
DLPN
•
